Drug and test developers face numerous challenges in today’s age of targeted therapies. Building the right tests and identifying partnership opportunities to drive precision medicine forward is just one of them.
In today’s era of shifting commercial landscapes, industry leaders recognize that to fully realize the promise of personalized medicine, a new model of collaboration between drug and test developers is essential for success. For many test developers, identifying and building relationships with the right Pharma partners early in their drug development process can be timely and expensive. Too often, it requires manually sifting through public databases, publications, conference materials, media and social channels in search of prospects, leaving the most high-value opportunities discovered too late or not at all.